|
1
|
RA Capital Management
Boston,
Massachusetts
|
$110M
|
–
|
–
|
–
|
|
|
2
|
|
$55.2M
|
+$3.36M
|
+376,000
|
+7%
|
|
|
3
|
Fidelity Investments
Boston,
Massachusetts
|
$50.6M
|
-$2.86M
|
-319,950
|
-6%
|
|
|
4
|
Cowen and Company
New York
|
$35.1M
|
+$2.14M
|
+240,000
|
+7%
|
|
|
5
|
Suvretta Capital Management
New York
|
$26.9M
|
-$23.8M
|
-2,670,395
|
-48%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$24M
|
+$167K
|
+18,681
|
+0.7%
|
|
|
7
|
TRV GP IV
Boston,
Massachusetts
|
$22.1M
|
–
|
–
|
–
|
|
|
8
|
|
$14.5M
|
-$184K
|
-20,657
|
-1%
|
|
|
9
|
Citadel Advisors
Miami,
Florida
|
$12.5M
|
-$701K
|
-78,494
|
-6%
|
|
|
10
|
Dimensional Fund Advisors
Austin,
Texas
|
$12.3M
|
+$2.94M
|
+329,533
|
+34%
|
|
|
11
|
|
$10.9M
|
-$11.4M
|
-1,280,981
|
-53%
|
|
|
12
|
Jefferies Financial Group
New York
|
$10.9M
|
-$2.51M
|
-281,590
|
-20%
|
|
|
13
|
MPM BioImpact
Boston,
Massachusetts
|
$10.7M
|
+$10.2M
|
+1,137,108
|
New
|
|
|
14
|
Adage Capital Partners
Boston,
Massachusetts
|
$10.4M
|
-$3.57M
|
-400,000
|
-27%
|
|
|
15
|
Millennium Management
New York
|
$8.47M
|
+$4.11M
|
+459,958
|
+105%
|
|
|
16
|
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$7.77M
|
–
|
–
|
–
|
|
|
17
|
|
$7.65M
|
-$547K
|
-61,233
|
-7%
|
|
|
18
|
Propel Bio Management
Los Angeles,
California
|
$7.08M
|
–
|
–
|
–
|
|
|
19
|
Rock Springs Capital Management
Baltimore,
Maryland
|
$6.87M
|
–
|
–
|
–
|
|
|
20
|
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$6.83M
|
+$4.29M
|
+480,255
|
+198%
|
|
|
21
|
Vestal Point Capital
New York
|
$6.56M
|
-$2.95M
|
-330,000
|
-32%
|
|
|
22
|
Simplify Asset Management
Las Vegas,
Nevada
|
$6.38M
|
+$1.01M
|
+112,706
|
+20%
|
|
|
23
|
|
$5.9M
|
+$1.14M
|
+127,497
|
+26%
|
|
|
24
|
Geode Capital Management
Boston,
Massachusetts
|
$5.32M
|
+$91.3K
|
+10,228
|
+2%
|
|
|
25
|
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$5.3M
|
-$943K
|
-105,601
|
-16%
|
|
